Novartis definitely know more about what Mesoblast is reporting to the market (ie. shareholders like you and I). You're going to buy into the optimism that SI shares when he makes the quarterly announcements.
Novartis' experience in this field allow them to see through the words and understand the statistics - particularly when it comes to what they're going to present to the OTAT.
Ann: Update on Novartis Agreement, page-300
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
-0.005(0.52%) |
Mkt cap ! $1.084B | |||
| Open | High | Low | Value | Volume |
| 96.0¢ | 98.5¢ | 91.5¢ | $4.743M | 4.999M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 123302 | 95.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.5¢ | 314 | 1 |
View Market Depth
| Last trade - 16.10pm 29/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |